NCT01321320View on ClinicalTrials.gov

Investigation of the Role of FHL-1 and Myostatin in Intensive Care Unit Acquired Paresis (ICUAP)

NACompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions
Intensive Care Unit Acquired ParesisMuscle Wasting
Interventions
OTHER

Active muscle stimulation

Neuromuscular Electrical stimulation will be applied to one leg (randomly assigned).

Trial Locations (1)

Unknown

National Heart and Lung Institute, Imperial College, London

Sponsors

Collaborators (1)

Medical Research Council
All Listed Sponsors
collaborator

Medical Research Council

OTHER_GOV

collaborator

Royal Brompton & Harefield NHS Foundation Trust

OTHER

lead

Imperial College London

OTHER

NCT01321320 - Investigation of the Role of FHL-1 and Myostatin in Intensive Care Unit Acquired Paresis (ICUAP) | Biotech Hunter | Biotech Hunter